Navigation Links
Roka Bioscience Atlas System For Food Pathogen Detection Integrated At Department of Defense Food Analysis and Diagnostic Laboratory
Date:9/25/2013

WARREN, N.J., Sept. 25, 2013 /PRNewswire/ -- Roka Bioscience announced today the adoption of the Atlas System at the Department of Defense Food Analysis and Diagnostic Laboratory (FADL) at Fort Sam Houston in San Antonio, Texas. The FADL has implemented the Atlas System along with the Atlas Listeria Detection Assay and the Atlas Salmonella Detection Assay, both of which have received AOAC Performance Tested™ certification. The FADL plans to use the Atlas System for high-volume sample testing for Listeria and Salmonella in foods that are provided to all US armed forces around the world.

(Photo: http://photos.prnewswire.com/prnh/20130228/NY67930

The Atlas System is an innovative fully automated molecular instrument for the detection of pathogens in food and environmental samples. This instrument utilizes a simple three-step procedure—Enrich, Transfer, Automate—and is capable of processing over 300 samples in 8 hours. The system's continuous workflow and high throughput provides greater efficiency, flexibility, and dynamic scalability to meet the ever-increasing demands placed on food safety laboratories.

The FADL protects the armed forces, ensuring food safety, fitness for consumption, and contractual compliance through microbiological, chemical, and toxicological testing of food and bottled water. The lab also provides technical consultation to the Department of Defense on integrating laboratory testing and food safety into science-based inspection systems.

"We are honored that the Department of Defense has chosen the Atlas System for its food safety testing," said Paul Thomas, CEO and President of Roka Bioscience. "With its high-throughput capabilities, accurate results, and unique technology, the Atlas System is ready for the important task of ensuring the food safety of our US troops domestically and overseas."

Roka Bioscience

Roka Bioscience is a privately held company focused on developing and commercializing innovative solutions based on molecular technologies for the industrial markets. The company's scientific platform is based on proven, proprietary technologies used widely in clinical diagnostic testing and now being introduced into food safety and other industrial markets. Roka's current product line provides food safety professionals with a fully automated molecular pathogen detection solution that delivers rapid, accurate results and improved laboratory efficiencies. For more information, visit www.rokabio.com

Contact:

Steve Sobieski
Chief Financial Officer (908) 605-4621
ssobieski@rokabio.com


'/>"/>
SOURCE Roka Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
2. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
3. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
4. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
5. Sangamo BioSciences Proposes Public Offering Of Common Stock
6. Curemark CEO To Deliver Keynote Address at the BioScience Vision Summit
7. Nanoly Bioscience to Develop CU-Boulder Vaccine Stabilization Technology
8. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
9. Regado Biosciences, Inc. Announces Exercise of Over-Allotment Option
10. Sanguine BioSciences Signs Agreements with More than 200 Partners to Enable Efficient Personalized Medicine Research
11. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , ... April 18, 2017 , ... A number of ... This webinar, which is part of the Protein and Cell Analysis Education Webinar ... outline where this technology fits in current and future applications. , Many flow ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark ... Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, ... trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... to novices as well as experienced users, attendees will gain a better understanding ... tests. , Hemostasis testing quality is determined by preanalytical variables which encompass ...
(Date:4/19/2017)... and WESTMINSTER, Colo. ... LLC ("Oxford"), an industry-leading specialty finance firm that ... services companies, today announced the closing of a ... Inc. ("Cerapedics") a privately-held orthobiologics company engaged in ... products for the treatment of orthopedic injuries. ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):